Mar. 14 at 1:34 PM
$RDW NASA Funding Highlights Redwire’s Space Pharma Ambitions And Valuation Debate. Redwire is trying to position itself in the broader space economy, not just as a hardware supplier but also as an in-orbit manufacturing partner.
✅ Price vs Analyst Target: At US
$9.59, Redwire trades about 29% below the US
$13.50 consensus price target.
NASA awards (RDW) additional funding to advance space-based pharmaceutical research.
The award expands an existing NASA contract focused on Redwire's Pharmaceutical In-space Laboratory technology.
The funding supports work on drug development in microgravity using Redwire's in-space laboratory platforms.
As this contract expands, you might want to monitor how Redwire describes its pipeline of in-space manufacturing projects, any potential collaborations with pharmaceutical companies, and the extent to which its future revenue mix could be associated with this kind of laboratory work.
